Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer

Not Applicable

• Conditions: Breast Cancer
• Interventions: Device: Hsp90

• Registration Number: NCT02324101
• Lead Sponsor: Protgen Ltd

Brief Summary

Detect plasma Hsp90α concentration of breast cancer patients, healthy volunteers, benign breast diseases patients

Detailed Description

Detect plasma Hsp90α concentration of breast cancer patients, healthy volunteers, benign breast diseases patients, validate accuracy, specificity and sensitivity of Hsp90α kit.

Study Timeline

• Status Verified: 2013-04
• Study Start: 2013-04
• Primary Completion: 2014-12
• Study Completion: 2014-12
• Study First Submitted: 2014-12-14
• Study First Submitted QC: 2014-12-22
• Last Update Submitted: 2014-12-22
• Study First Posted: 2014-12-24
• Last Update Posted: 2014-12-24

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1100

Inclusion Criteria

• breast cancer patients, healthy volunteers, benign breast diseases patients

Exclusion Criteria

• Patients who previously received radiotherapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Breast cancer	Hsp90	Detect plasma Hsp90α concentration of breast cancer patients

Primary Outcome Measures

Name	Time	Method
Hsp90α Concentration(ng/ml) of plasma	4 months	Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit

Trial Locations

Locations (1)

Tianjin cancer hospital; 🇨🇳 Tianjin, Tianjin, China